Agios Pharmaceuticals (AGIO) Shares Issued (2012 - 2026)

Agios Pharmaceuticals has reported Shares Issued for 15 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 28.35% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (down 10.41% YoY), and the FY2025 full-year result was $8.7 million, down 39.93% from the prior year.
• Shares Issued for Q1 2026 stood at $2.1 million, down from $2.6 million in the prior quarter.
• The five-year high for Shares Issued was $5.9 million in Q1 2024, with the low at $16000.0 in Q2 2022.
• Historically, Shares Issued has averaged $2.0 million across 5 years, with a median of $1.6 million in 2025.
• Annual changes were most pronounced in 2022 — Shares Issued slumped 99.94% — and 2023, when it surged 1381.25%.
• Agios Pharmaceuticals' Shares Issued stood at $105000.0 in 2022, then soared by 706.67% to $847000.0 in 2023, then jumped by 471.66% to $4.8 million in 2024, then sank by 47.19% to $2.6 million in 2025, then decreased by 18.73% to $2.1 million in 2026.
• The last three Shares Issued figures came in at $2.1 million (Q1 2026), $2.6 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.